home All News open_in_new Full Article

'Hold' Jubilant Pharmova Shares Maintains Systematix Post Inline Q2 Results

Jubilant Pharmova's sterile CMO and allergy Immunotherapy posts strong growth in Q2.


today 3 w. ago attach_file Politics

attach_file Events
attach_file Society
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics


ID: 170970341
Add Watch Country

arrow_drop_down